Latest News in the pharma Industry

Top Stories

Study: 19% Young Adults in U.S. Has High Blood Pressure

Study: 19% Young Adults in U.S. Has High Blood Pressure

26 May 2011

The study indicates that many young adults are at risk of developing heart disease, but are unaware that they have hypertension.

Read more 
Nestlé Acquires Prometheus Laboratories for $1.4 Billion

Nestlé Acquires Prometheus Laboratories for $1.4 Billion

26 May 2011

This acquisition is a strategic move into gastrointestinal diagnostics,' says Luis Cantarell, CEO of Nestlé Health Science.

Read more 
Valeant Pharma to Acquire AB Sanitas for $441M

Valeant Pharma to Acquire AB Sanitas for $441M

25 May 2011

Valeant Pharmaceuticals International Inc. will acquire a Lithuanian specialty pharmaceutical company in a two-stage deal worth $441.3 million.

Read more 
GSK Forms Partnership with Three NGOs

GSK Forms Partnership with Three NGOs

25 May 2011

GSK has formed a new partnership with three NGOs to deliver its reinvestments to improve health outcomes by supporting frontline health workers in LDCs.

Read more 
AstraZeneca Signs Co-promotion Deal with Daiichi Sankyo for Denosumab

AstraZeneca Signs Co-promotion Deal with Daiichi Sankyo for Denosumab

25 May 2011

Under the agreement, AstraZeneca and Daiichi Sankyo will co-promote denosumab after it is approved for use in Japan.

Read more 
Alcon Wins Patanol US Patent Infringement Lawsuit Against Apotex

Alcon Wins Patanol US Patent Infringement Lawsuit Against Apotex

25 May 2011

The court's decision would prevent Apotex from bringing its generic version of the drug to market prior to the Patanol patent expiration in 2015.

Read more 
Lilly Signs Agreements to Form Biotech Company

Lilly Signs Agreements to Form Biotech Company

24 May 2011

Eli Lilly and private investors Care Capital and NovaQuest Capital agreed to jointly create a biotechnology company to focus on Lilly's severe sepsis drug Xigris.

Read more 
Par Pharmaceutical to Acquire Indian Generics Company

Par Pharmaceutical to Acquire Indian Generics Company

24 May 2011

Par Pharmaceutical Cos. will acquire India-based generic drugmaker Edict Pharmaceuticals for up to $37.6 million.

Read more 
California Companies on Front Line against Heart Disease

California Companies on Front Line against Heart Disease

24 May 2011

The California companies are developing 188 of 887 drugs for more than 20 types of cancer and 55 of 299 medicines for heart disease and stroke.

Read more 
EMA Recommends Suspension of Oral Buflomedil-Containing Medicines

EMA Recommends Suspension of Oral Buflomedil-Containing Medicines

23 May 2011

The decision was taken because serious and sometimes fatal neurological and cardiac side effects, mainly related to accidental or intentional overdose, continued to occur.

Read more 
Takeda to Acquire Nycomed for $13.7B

Takeda to Acquire Nycomed for $13.7B

20 May 2011

Nycomed's significant business infrastructure in Europe and high-growth emerging markets are expected to enhance Takeda's regulatory development expertise and commercialization capability.

Read more 
Bill Gates Calls on Leaders for Vaccines Investment

Bill Gates Calls on Leaders for Vaccines Investment

19 May 2011

Bill Gates and his foundation calls on leaders to increase investment in vaccines and immunisation to make vaccines affordable for poor countries.

Read more